Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

798 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Bortezomib combination therapy in multiple myeloma.
Kapoor P, Ramakrishnan V, Rajkumar SV. Kapoor P, et al. Among authors: rajkumar sv. Semin Hematol. 2012 Jul;49(3):228-42. doi: 10.1053/j.seminhematol.2012.04.010. Semin Hematol. 2012. PMID: 22726546 Free PMC article. Review.
Current therapy for multiple myeloma.
Rajkumar SV, Gertz MA, Kyle RA, Greipp PR; Mayo Clinic Myeloma, Amyloid, and Dysproteinemia Group. Rajkumar SV, et al. Mayo Clin Proc. 2002 Aug;77(8):813-22. doi: 10.4065/77.8.813. Mayo Clin Proc. 2002. PMID: 12173715 Review.
Bone marrow angiogenesis in multiple myeloma: effect of therapy.
Kumar S, Fonseca R, Dispenzieri A, Lacy MQ, Lust JA, Witzig TE, Gertz MA, Kyle RA, Greipp PR, Rajkumar SV. Kumar S, et al. Among authors: rajkumar sv. Br J Haematol. 2002 Dec;119(3):665-71. doi: 10.1046/j.1365-2141.2002.03871.x. Br J Haematol. 2002. PMID: 12437642 Free article.
Review of 1027 patients with newly diagnosed multiple myeloma.
Kyle RA, Gertz MA, Witzig TE, Lust JA, Lacy MQ, Dispenzieri A, Fonseca R, Rajkumar SV, Offord JR, Larson DR, Plevak ME, Therneau TM, Greipp PR. Kyle RA, et al. Among authors: rajkumar sv. Mayo Clin Proc. 2003 Jan;78(1):21-33. doi: 10.4065/78.1.21. Mayo Clin Proc. 2003. PMID: 12528874
Plasma levels of tumour necrosis factor alpha and interleukin-6 predict progression-free survival following thalidomide therapy in patients with previously untreated multiple myeloma.
Thompson MA, Witzig TE, Kumar S, Timm MM, Haug J, Fonseca R, Greipp PR, Lust JA, Rajkumar SV. Thompson MA, et al. Among authors: rajkumar sv. Br J Haematol. 2003 Oct;123(2):305-8. doi: 10.1046/j.1365-2141.2003.04605.x. Br J Haematol. 2003. PMID: 14531913 Free article. Clinical Trial.
798 results